Skip to content
DraconiticResearch
Search Sources API
209,918 studies31 sourcesUpdated 56 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. Msh2 depletion impairs cell differentiation, proliferation and metabolism in esophageal organoids
    Marjorie Rolland, Dominique Jean, Maude Hamilton +5
    Journal of Cell SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Neutrophil-to-lymphocyte ratio is associated with in-hospital mortality in patients with cirrhosis and pneumonia: a multicenter retrospective study
    Hui Zhang, Lixia Huang, Pengpeng Sun +6
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMCEurope PMC
  3. Narrative review of non-pharmacological interventions for chemotherapy-induced peripheral neuropathy: exercise, physical therapy, cryotherapy and acupuncture
    Lingjun Li, Mingsi Fan, Li Ni +2
    Oncology reviewsPeer-reviewedCC BYFull textOncologyEurope PMCPMCEurope PMC
  4. Functional assessment of experimental lymphedema: a focused mini-review of animal models and measurement methods
    Shao-Yun Hsu, James Brandon Dixon, Zhanna Nepiyushchikh
    Frontiers in physiologyPeer-reviewedCC BYFull textOncologyEurope PMCPMCEurope PMC
  5. Hormone receptor–positive HER2-negative oligometastatic breast cancer: prognostic stratification and pattern of progression
    Jean-Louis Lacaze, Bastien Cabarrou, Thibaut Cassou-Mounat +10
    The OncologistPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  6. Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data.
    Seyedeh Zalfa Modarresi, Mahla Towhidifar, Somayeh Talaeipour +3
    Respiratory medicine case reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  7. Early-onset medication-related osteonecrosis of the jaw in adolescents with Duchenne muscular dystrophy receiving long-term antiresorptive combined with glucocorticoid therapy: Two case reports
    Agathe Rio, Patricia Olivier, Coralie Leblicq +2
    Bone reportsPeer-reviewedCC BY-NCFull textOncologyEurope PMCEurope PMCPMC
  8. Patient frustration with time spent on advanced ovarian and metastatic breast cancer care
    Allison Dona, Sarah J. Boyle, Patricia Jewett +10
    Gynecologic Oncology ReportsPeer-reviewedCC BYFull textOncologyDOAJEurope PMCEurope PMCPMC
  9. Recurrent leukaemia stem cell states define the antigenic landscape of paediatric Acute Myeloid Leukaemia
    S. Kanannejad, M. Oporto Espuelas, C. D'Oria +16
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  10. Inflammation is an essential trigger for POLE-driven ultramutated colorectal cancer
    M. K. Mustofa, M. Aguilar, H. Zhang +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  11. Dissecting KEAP1-NRF2 interactions: Structural and functional impact of cancer-associated KEAP1 mutants
    Q. Wang, W. Sopipong, G. Wells +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  12. A pan-cancer catalog of mutagenesis at transcription factor binding sites
    Harshit Sahay, Yuncheng Duan, Raluca Gordân
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  13. Hypoxia reduces induced LRIG1 protein despite sustained mRNA induction in colorectal cancer organoids
    A. Minamiura, S. Aoki, R. Matsuwaka +6
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  14. Functional heterogeneity, tumor vascularization, and the nonlinear dynamics of metastatic cancer treated by oncolytic viral therapy
    T. P. Evans, M. Martin
    bioRxivPreprintCC BYFull textOncologybioRxiv
  15. Targeting poorly differentiated thyroid cancer with bispecific antibodies and CAR T cells from the human anti-TSHR autoantibody repertoire
    C. Fischer, A. Eugster, B. Besemer +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  16. A comprehensive temporal proteome and phosphoproteome dataset of Y1 adrenocortical cells under FGF2 stimulation and SOS inhibition
    F. Montoni, T. Hanada, K. Doi +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  17. Estradiol Modulates Cytotoxic Responses to Topoisomerase II Targeting Agents in Estrogen Receptor Positive Breast Cancer Cells
    N. Thomas, N.-Y. Sun, M. Cherian
    bioRxivPreprintCC BYFull textOncologybioRxiv
  18. A First-in-Class LZK Inhibitor Suppresses Tumor Growth and Potentiates EGFR and PI3K Pathway Blockade in Head and Neck and Esophageal Cancers
    Meghri Katerji, Kailey N. Jackett, Maxine R. Rubin +20
    bioRxivPreprintCC BYFull textOncologybioRxivEurope PMCPMC
  19. From Binding Sites to Target Genes: Reframing Human microRNA Target Prediction.
    Stephanie Sammut, Elissavet Zacharopoulou, Dimosthenis Tzimotoudis +1
    Non-coding RNAPeer-reviewedCC BYFull textOncologyEurope PMC
  20. General Practitioner Sex and Documented Cancer Prevalence in German Primary Care: A Matched Cross-Sectional Study.
    Karel Kostev, Isabel Klein, Svetlana Alymova +1
    Epidemiologia (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  21. Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic Cancer.
    Jessica L Nickerson, Stefanie Condon-Oldreive, Erica Tsang +13
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  22. Adjuvant Trastuzumab Deruxtecan Versus Trastuzumab Emtansine by Residual Cancer Burden in HER2-Positive Early Breast Cancer: A Decision Analysis
    Jane Fan, Axel Stenmark Tullberg, Allison W. Kurian +3
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxivPMC
  23. Source-linked multispecialty clinical reasoning and tumour-board decision-making in colorectal cancer
    V. A. Gombolevskiy, M. I. Sekacheva, V. D. Sanikovich +10
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  24. Peripheral Biomarkers and Determinants of Survival for Patients with Melanoma Brain Metastasis Treated with Immune Checkpoint Blockade
    J. Hassan, M. Little, A. Farkas +5
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  25. Sturgeon V2: a clinically applicable CNS tumor classifier trained on relabeled data
    C. Vermeulen, H. van der Ent, S. L. Maas +24
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv